ArticleBlood advances2020

Elevated plasma levels of syndecan-1 and soluble thrombomodulin predict adverse outcomes in thrombotic thrombocytopenic purpura.

Ruinan Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.